Interviewer-Perceived Honesty as a Mediator of Racial Disparities in the Diagnosis of Schizophrenia
Abstract
Objective:
African Americans are disproportionately diagnosed as having schizophrenia, and the factors that contribute to this disparity are poorly understood. This study utilized data from the 1995 MacArthur Violence Risk Assessment Study to examine the impact of racial differences in sociodemographic characteristics, clinical presentation, and perceived honesty on disparities in the diagnosis of schizophrenia among African Americans.
Methods:
Researchers using structured assessments of diagnostic, sociodemographic, and clinical measures interviewed African Americans (N=215) and whites (N=537) receiving inpatient care for a severe mental illness. The impact of interviewers' perceptions of the participants' honesty on racial disparities in the diagnosis of schizophrenia was assessed.
Results:
African Americans (45%) were more than three times as likely as whites (19%) to be diagnosed as having schizophrenia. Disparities in sociodemographic and clinical characteristics modestly contributed to disparities in diagnostic rates. In contrast, interviewer-perceived honesty proved to be a significant predictor of racial disparities in schizophrenia diagnoses. After adjustment for perceived honesty, diagnostic disparities between African Americans and whites were substantially reduced. Mediator analyses confirmed that interviewer-perceived honesty was the only consistent mediator of the relationship between race and schizophrenia diagnosis.
Conclusions:
Interviewers' perceptions of honesty among African-American participants are important contributors to disparities in the diagnosis of schizophrenia. Clinicians' perceptions of dishonesty among African-American patients may reflect poor patient-clinician relationships. Methods of facilitating a trusting relationship between patients and clinicians are needed to improve the assessment and treatment of persons from minority groups who are seeking mental health care. (Psychiatric Services 63:875–880, 2012; doi: 10.1176/appi.ps.201100388)
Disparities in mental health services and outcomes among persons from racial minority groups across a range of psychiatric conditions (1,2), including schizophrenia, have been widely documented (3). These disparities have been particularly prominent among African Americans, who receive fewer mental health services (4), more coercive methods of care (5–8), and poorer quality of treatment (9,10). Not surprisingly, such differences in the quality and nature of mental health services received by African Americans have led to significantly poorer outcomes (11).
One of the most striking and consistent disparities among African Americans seeking mental health services is the increased diagnosis of schizophrenia (12–17). This phenomenon exists despite the absence of unique genetic evidence to indicate a true increase in prevalence in this population (18,19), although some increase in prevalence may be due to environmental risk factors (20). Bias in the diagnosis of schizophrenia among African Americans has the potential to have a monumental impact on care, given that approaches indicated for treatment of psychotic versus mood disorders vary considerably and the receipt of an unneeded antipsychotic treatment regimen may have severe adverse consequences (21). As such, an important priority in reducing disparities in mental health outcomes among African Americans has been understanding and reducing diagnostic bias.
Unfortunately, remarkably little is known about the factors or mechanisms that contribute to the overrepresentation of schizophrenia diagnoses affecting the African-American community. Efforts to pinpoint the sources of diagnostic bias in this population have primarily examined differences in the sociodemographic characteristics and the clinical presentations of individuals seeking care. After adjustment for differences in socioeconomic status (12,22) and symptomatology (17), these studies have continued to find increased diagnoses of schizophrenia among African Americans.
Recently, investigators of potential racial biases in the diagnosis of schizophrenia have begun to turn their attention toward clinician behavior and characteristics. Evidence suggests that clinicians use different symptom criteria when making schizophrenia diagnoses among African Americans (23), a practice that is not remediated by the use of a structured clinical interview (24). Further, increased diagnosis of schizophrenia among African Americans by African-American and white clinicians appears to be equally prevalent (25). Clinicians also appear to perceive African-American clients as more paranoid and suspicious in general (17,26), which could contribute to elevated rates of psychotic diagnoses in this population. Indeed, recent popular literature has extensively discussed how schizophrenia became a “black” diagnosis, in part because of cultural mistrust between the two racial groups and what whites perceived as obstinacy by blacks fighting for civil rights (27). Currently, however, few empirical data exist about the impact of the patient-clinician relationship, such as clinician perceptions of a patient's honesty and trust, on disparities in the diagnosis of schizophrenia among African Americans.
This study investigated the degree to which sociodemographic characteristics, clinical presentation, and interviewer perceptions of patient honesty served as mechanisms of racial disparities in diagnostic rates of schizophrenia. We hypothesized that differences in the sociodemographic characteristics and clinical presentation of African Americans and whites upon hospital admission would contribute to the overrepresentation of African Americans among patients diagnosed as having schizophrenia. In addition, we hypothesized that independent of any differences in clinical presentation, perception by the interviewer of the honesty of the patient would also contribute significantly to disparities in schizophrenia diagnoses.
Methods
Participants
Participants consisted of 752 individuals with a major depressive disorder (57%, N=432), schizophrenia or schizoaffective disorder (26%, N=198), or bipolar disorder (16%, N=122) enrolled in the multisite MacArthur Violence Risk Assessment Study (28). Completed in 1995, data collection by the study involved uniquely in-depth research assessments of a large number of participants, including assessments by the research interviewers of their interactions with participants. The study oversampled African Americans and collected both independent research data and diagnostic data from participants' charts. Together these data allowed for a comprehensive examination of racial disparities in the diagnosis of schizophrenia using multiple methodologies.
Individuals were recruited from psychiatric inpatient units located in the major metropolitan areas of Pittsburgh, Pennsylvania; Worcester, Massachusetts; and Kansas City, Missouri. Eligibility criteria consisted of a DSM-III-R diagnosis in the participant's chart of a severe mental illness (schizophrenia, schizophreniform disorder, schizoaffective disorder, major depressive disorder, dysthymic disorder, bipolar disorder, brief reactive psychosis, delusional disorder, substance abuse or dependence, or personality disorder), current hospitalization of fewer than 21 days, age 18 to 40 years, and the ability to read and speak fluent English. The study recruited 1,695 participants, and 1,136 (67%) were enrolled.
Because this study investigated racial disparities among patients with diagnoses of schizophrenia-spectrum versus major mood disorders, we included only the 752 individuals diagnosed as having schizophrenia or schizoaffective, major depressive, or bipolar disorder. The 21 Hispanic individuals in the sample were also excluded because of their limited numbers. On average, participants were 29.99±6.20 years old; half (54%, N=406) were male, and 29% (N=215) were African American. Over half of the individuals (58%, N=438) had never been married, most (75%, N=561) had been hospitalized for a psychiatric condition previously, and a majority (72%, N=542) were currently hospitalized voluntarily.
Measures
Psychiatric diagnosis.
Principal psychiatric diagnoses were obtained by using two separate methods. First, a thorough review of the psychiatric records of the participant was conducted to obtain the latest clinic diagnosis. Second, participants completed a research diagnostic interview using the DSM-III-R Criteria Checklist (29), a structured interview and checklist of diagnostic symptoms of DSM disorders. The interview covers all axis I diagnostic categories and, most important, does not allow interviewers to circumvent certain diagnostic categories on the basis of their own judgments or information they receive during the interview. This is accomplished by requiring interviewers to review all inclusion and exclusion criteria for all axis I disorders in the DSM during the interview. The DSM-III-R Checklist has been validated for diagnosis of psychiatric disorders (29–31) and has been used successfully in previous studies of racial disparities in psychiatric diagnosis (23).
Psychiatric symptomatology.
Psychopathology was assessed by using the Brief Psychiatric Rating Scale (BPRS) (32) and the Auditory Hallucinations Schedule (28). The BPRS is a widely used measure of psychiatric symptomatology that has good psychometric properties (33), with higher scores reflecting greater levels of symptomatology. The Auditory Hallucinations Schedule, a semistructured interview designed to characterize auditory hallucinations among individuals with psychotic conditions, was used to establish the presence of auditory hallucinations. Finally, the presence of delusions was assessed by the DSM-III-R Checklist.
Perceived honesty.
To obtain information on the interaction between the interviewer and the participant during diagnostic and clinical assessments, interviewers completed a questionnaire after conducting each interview. This questionnaire was originally completed for quality assurance purposes and consisted of ratings of the perceived honesty of the participant during the interview. Such information provided a unique opportunity to begin to examine the impact of the patient-clinician interaction on diagnostic decisions. Perceived honesty was rated on a 5-point scale, ranging from 1 (honest) to 5 (untruthful), in response to the question, “Did the subject appear to be answering honestly?” Separate ratings were obtained for the participant's responses during assessment of diagnosis, delusions, and hallucinations. Ratings of perceived honesty across participants were highly interrelated and, therefore, were averaged. The resulting interviewer-perceived honesty scale combining these ratings demonstrated excellent internal consistency (α=.87).
Socioeconomic status.
Hollingshead and Redlich's index (34) was used to measure socioeconomic status by taking into account prehospitalization education and occupation.
Procedures
Research interviewers assessed the participants during their stay at one of the inpatient units. Careful attention was paid to ensure that individuals were capable of providing informed consent to participate in the study as well as capable of completing the study assessments. This study was approved and reviewed annually by the institutional review board of each study site, and all enrolled individuals provided written, informed consent prior to participation.
Data analysis
Disparities in rates of diagnosis of schizophrenia among African Americans and whites were investigated. Systematic differences in the demographic and clinical characteristics and in the interviewers' perceptions of honesty of participants of different races were examined with independent t tests or with Fisher's exact test (for categorical variables). A series of logistic regression models was used to examine whether variables that were significantly associated with race contributed to the effects of race on the diagnosis of schizophrenia. Finally, multiple mediation models using Baron and Kenny's (35) approach examined whether sociodemographic, clinical, and perceived honesty characteristics that demonstrated significant associations with both race and a schizophrenia diagnosis mediated the effect of race on schizophrenia diagnosis. The indirect effect of race on outcome through the mediator was subsequently calculated by using the product-of-coefficients method (35), and the significance of indirect effects was tested by using the asymptotic z test for indirect effects outlined by MacKinnon and colleagues (36).
Results
Racial disparities
As shown in Table 1, 19% of the white sample received a research diagnosis of schizophrenia or schizoaffective disorder compared with nearly half (45%) of the African-American sample. This difference represented over a threefold increase in the rates of schizophrenia spectrum disorders among African Americans compared with whites. Differences in the two groups' chart diagnoses were of a similar magnitude (data not shown). Significant differences between the races in a variety of sociodemographic and clinical characteristics were also present. Compared with whites, the African Americans in the sample were slightly older and had lower socioeconomic status. Further, they tended to experience greater rates of hallucinations, delusions, and substance use problems and had greater levels of psychiatric symptomatology, particularly thought disturbance. In addition, interviewers consistently perceived African Americans to be less honest than whites during diagnostic interviews.
Mechanisms of racial disparities
A series of logistic regression models were conducted to examine the degree to which disparities in sociodemographic and clinical characteristics contributed to the increased diagnosis of schizophrenia among African Americans. Results revealed numerous predictors of the diagnosis of schizophrenia, both from the chart review and the research diagnostic assessment (Table 2). Older individuals who had never married were significantly more likely to be diagnosed as having schizophrenia, but socioeconomic status was an inconsistent predictor of a schizophrenia diagnosis. As expected, individuals experiencing delusions and other schizophrenia symptomatology, such as thought disturbance and anergia, were more likely to be diagnosed as having the disorder. However, even after adjustment for demographic and clinical characteristics that were highly significant predictors of a schizophrenia diagnosis, being African American continued to place individuals at an over threefold risk of receiving a research diagnosis of schizophrenia.
Given that clinical and demographic characteristics could not account for the increased diagnosis of schizophrenia among African Americans, we studied the contribution of perceived honesty during the research interview. As shown in Table 2, individuals were nearly one-and-a-half times as likely to receive a schizophrenia diagnosis if the interviewer perceived them to be dishonest during diagnostic assessments. Further, after adjustment for the impact of perceived honesty, the effect of being African American on receiving a diagnosis of schizophrenia in one's chart was no longer statistically significant, and its effect on receipt of a research interview diagnosis of schizophrenia was markedly reduced.
Mediator analyses indicated that few sociodemographic or clinical characteristics significantly mediated the effect of race on the diagnosis of schizophrenia (Table 3). The presence of auditory hallucinations significantly mediated the effect of race on research interview diagnoses, but not on chart diagnoses, of schizophrenia. The absence of substance abuse significantly mediated the effect of race on chart diagnoses, but not on research interview diagnoses, of schizophrenia. In contrast, interviewers' perceptions of participants' honesty represented the strongest and only consistent mediator of racial disparities in the diagnosis of schizophrenia by both diagnostic methodologies. Taken together, these findings indicated that clinician perceptions of honesty and the relationship between the interviewer and the participant were important and potentially unique contributors to racial disparities in the diagnosis of schizophrenia.
Discussion
Disparities in access, availability, and quality of mental health services and treatment among African Americans have been repeatedly documented (1,3). One of the most consistent disparities, an increase in the diagnosis of schizophrenia, has the potential to significantly impact mental health outcomes of this population (16,17). To date, however, few studies have examined the potential mechanisms driving this diagnostic disparity.
We investigated the degree to which sociodemographic and clinical characteristics and interviewer-perceived honesty independently served as mechanisms contributing to the diagnosis of schizophrenia among African Americans. As predicted, among the strongest contributors to racial disparities in the diagnosis of schizophrenia was whether the research interviewer perceived the participant to be honest and trustworthy during their interaction. Further, interviewer-perceived honesty proved to be the only consistent mediator of the increased diagnosis of schizophrenia among African Americans. These findings point to the potentially important contribution of the patient-clinician relationship to race-related disparities in the diagnosis of schizophrenia. This relationship appears to affect such disparities as much as, if not more than, the clinical presentation of the patient.
Studies of racial disparities in mental health diagnoses have consistently underscored the potential importance of the patient-clinician relationship (17,23,25). This research is the first to document directly that perceived honesty during diagnostic interviews is an important mediator of racial disparities in the diagnosis of schizophrenia. The findings indicate that a fundamental challenge to psychiatric assessment of African Americans is developing a trusting, open, and collaborative relationship, which has been identified as essential to effective care of minority populations (37,38). Unfortunately, the context of a diagnostic assessment often poses some unique challenges to developing a trusting therapeutic relationship with patients, given that assessments are commonly conducted in a single session by a clinician who has only just met the patient and frequently must be rendered quickly to support an inpatient admission or other immediate referral. Future research efforts might profitably employ a longitudinal diagnostic assessment system that emphasizes developing an empathic trusting relationship between the patient and the clinician.
Although this research has several implications for how to address racial disparities in the diagnosis of schizophrenia, such implications need to be understood in the context of a number of limitations. First, assessments of patient-clinician trust and interactions were limited to completion by the interviewer of a single measure of the participant's perceived honesty, which was based on a small number of ratings from diagnostic and assessment interviews. Although this measure demonstrated good internal consistency, an important limitation was the absence of information about the participant's perceptions of the interaction. There are many reasons why a patient might be perceived as not completely honest and forthcoming, and without the perspective of the patient and further examination of the patient-clinician interaction, such reasons remain elusive.
One possibility is that African Americans were completely honest during the interviews but that clinicians held a racial bias in perceptions of honesty. It is also possible that the ratings of greater dishonesty among African Americans reflect not so much a perception of untruthfulness but an acknowledgment of the increased presentation of unusual or inconsistent information common in schizophrenia. It will be important for future studies to examine more comprehensively the patient-clinician relationship to clarify sources of mistrust and interviewer biases. In addition, this study examined perceived honesty among only research interviewers, and thus these findings may not generalize to nonresearch settings. Although interviewer-perceived honesty was related to increased diagnoses of schizophrenia both during structured research interviews and in chart diagnoses, future studies are needed to examine the impact of perceptions of honesty and the patient-clinician relationship outside a research setting.
Second, psychiatric diagnoses were based upon DSM-III-R, the diagnostic standard at the time of the MacArthur study, which may have affected our findings. Although DSM-IV introduced important changes, few differences exist between the diagnostic classification of schizophrenia in DSM-III-R and the current version, DSM-IV-TR. In addition, studies based on DSM-IV also continue to document disparities in the diagnosis of schizophrenia among African Americans at rates similar to those observed by this study (39). As such, these findings are not likely to be appreciably affected by changes in the diagnostic criteria for schizophrenia. Third, disparities in quality of care also could have contributed to the overrepresentation in this inpatient sample of African Americans diagnosed as having schizophrenia, although previous studies have also suggested racial disparities in schizophrenia diagnoses in outpatient settings (14).
Finally, this study was limited to an inpatient sample, which may affect the generalizability of the findings to individuals receiving psychiatric assessments in outpatient settings. To date, a majority of studies have focused on the diagnosis of schizophrenia in inpatient or psychiatric emergency settings. Whether racial disparities in diagnoses exist in outpatient settings, where patients may have the opportunity to develop a more personal relationship with the diagnostician, remains an important question.
Conclusions
This study revealed that interviewer perceptions of patients' honesty are significant and strong mediators of racial disparities in the diagnosis of schizophrenia among African Americans. Despite limited assessment of the patient-clinician relationship and restriction to an inpatient sample, our findings highlight the importance of understanding and seeking ways to improve the clinician-patient working alliance with members of underserved ethnic and racial minority groups during psychiatric assessment to improve the care of such individuals during treatment.
Acknowledgments and disclosures
Dr. Eack has served as a scientific consultant for Abbott Laboratories. The other authors report no competing interests.
References
1.
McGuire TG, Miranda J: New evidence regarding racial and ethnic disparities in mental health: policy implications. Health Affairs 27:393–403, 2008
2.
Mental Health: Culture, Race, and Ethnicity: A Supplement to Mental Health: A Report of the Surgeon General. Rockville, Md, US Department of Health and Human Services, US Public Health Service, 2001
3.
Rost K, Hsieh YP, Xu S, et al.: Potential disparities in the management of schizophrenia in the United States. Psychiatric Services 62:613–618, 2011
4.
Neighbors HW, Caldwell C, Williams DR, et al.: Race, ethnicity, and the use of services for mental disorders: results from the National Survey of American Life. Archives of General Psychiatry 64:485–494, 2007
5.
Citrome L, Levine J, Allingham B: Utilization of depot neuroleptic medication in psychiatric inpatients. Psychopharmacology Bulletin 32:321–326, 1996
6.
Rosenfield S: Race differences in involuntary hospitalization: psychiatric vs labeling perspectives. Journal of Health and Social Behavior 25:14–23, 1984
7.
Segal SP, Bola JR, Watson MA: Race, quality of care, and antipsychotic prescribing practices in psychiatric emergency services. Psychiatric Services 47:282–286, 1996
8.
Snowden LR, Hastings JF, Alvidrez J: Overrepresentation of black Americans in psychiatric inpatient care. Psychiatric Services 60:779–785, 2009
9.
Busch AB, Lehman AF, Goldman H, et al.: Changes over time and disparities in schizophrenia treatment quality. Medical Care 47:199–207, 2009
10.
Horvitz-Lennon M, McGuire TG, Alégria M, et al.: Racial and ethnic disparities in the treatment of a Medicaid population with schizophrenia. Health Services Research 44:2106–2122, 2009
11.
Eack SM, Newhill CE: Racial disparities in mental health outcomes after psychiatric hospital discharge among individuals with severe mental illness. Social Work Research, in press
12.
Barnes A: Race and hospital diagnoses of schizophrenia and mood disorders. Social Work 53:77–83, 2008
13.
Bresnahan M, Begg MD, Brown A, et al.: Race and risk of schizophrenia in a US birth cohort: another example of health disparity. International Journal of Epidemiology 36:751–758, 2007
14.
Dixon L, Green-Paden L, Delahanty J, et al.: Variables associated with disparities in treatment of patients with schizophrenia and comorbid mood and anxiety disorders. Psychiatric Services 52:1216–1222, 2001
15.
Minsky S, Vega W, Miskimen T, et al.: Diagnostic patterns in Latino, African American, and European American psychiatric patients. Archives of General Psychiatry 60:637–644, 2003
16.
Strakowski SM, Flaum M, Amador X, et al.: Racial differences in the diagnosis of psychosis. Schizophrenia Research 21:117–124, 1996
17.
Trierweiler SJ, Neighbors HW, Munday C, et al.: Clinician attributions associated with the diagnosis of schizophrenia in African American and non-African-American patients. Journal of Consulting and Clinical Psychology 68:171–175, 2000
18.
Calkins ME, Tepper P, Gur RC, et al.: Project Among African-Americans to Explore Risks for Schizophrenia (PAARTNERS): evidence for impairment and heritability of neurocognitive functioning in families of schizophrenia patients. American Journal of Psychiatry 167:459–472, 2010
19.
Wiener HW, Klei L, Irvin MD, et al.: Linkage analysis of schizophrenia in African-American families. Schizophrenia Research 109:70–79, 2009
20.
Dealberto MJ: Ethnic origin and increased risk for schizophrenia in immigrants to countries of recent and longstanding immigration. Acta Psychiatrica Scandinavica 121:325–339, 2010
21.
McEvoy JP, Meyer JM, Goff DC, et al.: Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophrenia Research 80:19–32, 2005
22.
Bresnahan M, Begg MD, Brown A, et al.: Race and risk of schizophrenia in a US birth cohort: another example of health disparity. International Journal of Epidemiology 36:751–758, 2007
23.
Neighbors HW, Trierweiler SJ, Ford BC, et al.: Racial differences in DSM diagnosis using a semi-structured instrument: the importance of clinical judgment in the diagnosis of African Americans. Journal of Health and Social Behavior 44:237–256, 2003
24.
Neighbors HW, Trierweiler SJ, Munday C, et al.: Psychiatric diagnosis of African Americans: diagnostic divergence in clinician-structured and semistructured interviewing conditions. Journal of the National Medical Association 91:601–612, 1999
25.
Trierweiler SJ, Neighbors HW, Thompson EE, et al.: Differences in patterns of symptom attribution in diagnosing schizophrenia between African American and non-African-American clinicians. American Journal of Orthopsychiatry 76:154–160, 2006
26.
Whaley AL: Cultural mistrust and the clinical diagnosis of paranoid schizophrenia in African-American patients. Journal of Psychopathology and Behavioral Assessment 23:93–100, 2001
27.
Metzl JM: The Protest Psychosis: How Schizophrenia Became a Black Disease. Boston, Beacon, 2010
28.
Monahan J, Steadman H, Silver E, et al.: Rethinking Risk Assessment: The MacArthur Study of Mental Disorder and Violence. New York, Oxford University Press, 2001
29.
Janca A, Helzer J: DSM-III-R Criteria Checklist. Diagnostic Interview Schedule Newsletter 7:17, 1990
30.
Hudziak JJ, Helzer JE, Wetzel MW, et al.: The use of the DSM-III-R Checklist for initial diagnostic assessments. Comprehensive Psychiatry 34:375–383, 1993
31.
Steadman HJ, Mulvey EP, Monahan J, et al.: Violence by people discharged from acute psychiatric inpatient facilities and by others in the same neighborhoods. Archives of General Psychiatry 55:393–401, 1998
32.
Overall JE, Gorham DR: The Brief Psychiatric Rating Scale. Psychological Reports 10:799–812, 1962
33.
Faustman WO, Overall JE: Brief Psychiatric Rating Scale; in The Use of Psychological Testing for Treatment Planning and Outcome Assessment. Edited by, Hillsdale Maruish M. NJ, Erlbaum, 1999
34.
Hollingshead AB, Redlich FC: Social Class and Mental Illness: A Community Study. New York, Wiley, 1958
35.
Baron RM, Kenny DA: The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology 51:1173–1182, 1986
36.
MacKinnon DP, Lockwood CM, Hoffman JM, et al.: A comparison of methods to test mediation and other intervening variable effects. Psychological Methods 7:83–104, 2002
37.
Davis LE, Proctor EK: Race, Gender, and Class: Guidelines for Practice With Individuals, Families, and Groups. Boston, Allyn and Bacon, 1989
38.
Franklin AJ: Therapy with African-American men. Families in Society 73:350–355, 1992
39.
Anglin DM, Malaspina D: Ethnicity effects on clinical diagnoses compared to best-estimate research diagnoses in patients with psychosis: a retrospective medical chart review. Journal of Clinical Psychiatry 69:941–945, 2008
Figures and Tables
Information & Authors
Information
Published In
Cover: Candy Apples, by Wayne Thiebaud, 1964/1990. Watercolor over hand-ground and dry-point etching, 5 × 5 inches. Gift of Mr. and Mrs. Paul LeBaron Thiebaud, 1996.19. Kemper Museum of Contemporary Art, Kansas City, Missouri.
History
Published online: 1 September 2012
Published in print: September 2012
Authors
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
View Options
View options
PDF/EPUB
View PDF/EPUBLogin options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).